Displaying 741 - 760 of 1043 results

NIAMS Concept Clearances

https://www.niams.nih.gov/es/node/3526

Concept clearance is the planning process that begins approximately two years prior to any potential funding. NIAMS receives input from the National Arthritis and Musculoskeletal and Skin Diseases Advisory Council (NAMSAC) regarding the merits of proposed research concepts. The concepts listed here have been presented and discussed at previous NAMSAC meetings.

FY 2016 Funding Plan

https://www.niams.nih.gov/es/node/2930

The NIAMS provides the 2016 interim funding plan for research and training grants. The NIAMS is operating under the FY 2016 Omnibus Appropriations bill. The funding plan below for research and training grants represents the most current information as of the date cited above; however, many factors occurring throughout the fiscal year can affect the operating policies, thus they are subject to change.

FY 2015 Funding Plan

https://www.niams.nih.gov/es/node/2931

The NIAMS is operating under the Consolidated and Further Continuing Appropriations Act of 2015. The funding plan below for research and training grants represents the most current information as of the date cited above; however, many factors occurring throughout the fiscal year can affect the operating policies, thus they are subject to change.

Nuestra misión

https://www.niams.nih.gov/es/acerca/nuestra-mision

La misión del Instituto Nacional de Artritis y Enfermedades Musculoesqueléticas y de la Piel (NIAMS, por sus siglas en inglés) es apoyar las investigaciones científicas sobre las causas, los tratamientos y la prevención de la artritis y las enfermedades musculoesqueléticas y de la piel, capacitar a los científicos en investigación

Funding Patterns Fiscal Year 2018

https://www.niams.nih.gov/es/node/8041

January 06, 2020 The decision to fund or not to fund a particular application is based on the assessment of scientific merit by a peer review group and on the relevance of the proposed work to the Institute's scientific and health priorities. Peer reviewers' judgments of scientific merit are expressed

Subset Analysis in Clinical Studies Roundtable - March 11, 2020

https://www.niams.nih.gov/es/node/8261

See participant list See Backgrounder Summary Welcome (Bob Carter, 0:00 1) Dr. Carter provided an overview of why NIAMS was holding this meeting (see background), acknowledged key staff who were involved in its development, and urged participants to keep the discussions focused on the scientific needs and opportunities related to subset analysis in clinical studies. He asked everyone to think broadly about how the various statistical approaches could be applied to NIAMS mission areas and to share their contributions during the afternoon discussion. 1 Times are noted in approximate hours and minutes on the videocast. The link does not take

Typically materials from NIAMS that are more than 5 years old will be archived.

Inicio de página